Patents by Inventor MANUEL MAMELI

MANUEL MAMELI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
    Patent number: 10413541
    Abstract: A method of treating a depressive or stress disorder in a subject afflicted therewith comprising administering to the subject an effective amount of a compound having the structure:
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: September 17, 2019
    Assignee: Lixte Biotechnology, Inc.
    Inventors: John S. Kovach, Salvatore Lecca, Manuel Mameli
  • OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DEPRESSIVE AND STRESS DISORDERS
    Publication number: 20180256565
    Abstract: A method of treating a depressive or stress disorder in a subject afflicted therewith comprising administering to the subject an effective amount of a compound having the structure:
    Type: Application
    Filed: November 17, 2017
    Publication date: September 13, 2018
    Inventors: John S. Kovach, Salvatore Lecca, Manuel Mameli
  • Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
    Patent number: 9833450
    Abstract: A method of treating a depressive or stress disorder in a subject afflicted therewith comprising administering to the subject an effective amount of a compound having the structure:
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: December 5, 2017
    Assignees: LIXTE BIOTECHNOLOGY, INC., INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
    Inventors: John S Kovach, Salvatore Lecca, Manuel Mameli
  • OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DEPRESSIVE AND STRESS DISORDERS
    Publication number: 20160303115
    Abstract: A method of treating a depressive or stress disorder in a subject afflicted therewith comprising administering to the subject an effective amount of a compound having the structure:
    Type: Application
    Filed: February 19, 2016
    Publication date: October 20, 2016
    Applicants: Lixte Biotechnology, Inc., Institut national de la santé et de la recherche médicale
    Inventors: JOHN S. KOVACH, SALVATORE LECCA, MANUEL MAMELI